scholarly article | Q13442814 |
P2093 | author name string | Shoyab M | |
Grove RI | |||
Radka SF | |||
Kiener PA | |||
Mazzucco CE | |||
P433 | issue | 27 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lipoprotein | Q28350 |
P304 | page(s) | 18194-18199 | |
P577 | publication date | 1991-09-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism | |
P478 | volume | 266 |
Q24678972 | AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies |
Q41030491 | Acute Myelogenous Leukemia Cells Secrete Factors that Stimulate Cellular LDL Uptake via Autocrine and Paracrine Mechanisms |
Q42085286 | Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression |
Q43857501 | Growth modulation of low density lipoprotein receptor sterol sensitivity in cultured human fibroblasts |
Q38358416 | Oncostatin m modulation of lipid storage |
Q40339285 | Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth |
Q31729241 | Soy proteins and cardiovascular disease. |
Q42778019 | Stimulation of low-density lipoprotein uptake in HepG2 cells by epidermal growth factor via a tyrosine kinase-dependent, but protein kinase C-independent, mechanism |
Q41021757 | Stimulation of rat hepatic low density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo |
Q52365247 | The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation. |
Q37409222 | The enigmatic cytokine oncostatin m and roles in disease |
Q41439236 | Upregulation of low density lipoprotein receptor activity by tumor necrosis factor, a process independent of tumor necrosis factor-induced lipid synthesis and secretion |
Search more.